ST LOUIS, US/NESS ZIONA, ISRAEL: Monsanto Company and NRGene have reached a non-exclusive, multi-year global licensing agreement on NRGene’s genome analysis technology. To enhance Monsanto’s ability to predict, compare and select the best genetic makeup from its vast data sets of genetic, genomic and trait information.
NRGene, a leading genomic big data company, develops advanced computational tools and cutting-edge algorithmic models to facilitate optimal trait discovery for seed companies, animal breeders, and academia.
NRGene’s platform, GenoMAGIC, was developed by a unique mix of highly experienced algorithm designers, software engineers, plant breeders and plant geneticists and is used by seed companies and major academic and research institutions around the world.
Both companies noted their dedication to developing technologies that support farmers as they work to grow better harvests, protect their crops and deliver more to society in the face of mounting environmental challenges. Monsanto’s research and development (R&D) pipeline is focused on providing solutions to those challenges through plant breeding, plant biotechnology, crop protection, ag biologicals, and data science.
With nearly half of Monsanto’s annual R&D investment focused on plant breeding, the use of leading genome analysis technologies like GenoMAGIC – along with the industry’s largest testing capability and scale and premier discovery technologies – are expected to increase current genetic gain. Monsanto may expand its relationship with NRGene into a longer-term commitment following an in-depth evaluation of the technology. The GenoMAGIC platform extends Monsanto's capabilities for genome selection, trait discovery, and genome enhancement.
“Monsanto employs best-in-class data analytics technologies to help unlock the genetic potential of our research and development pipeline for our farmer customers. Our focus on data is allowing us to make better decisions than ever before – and with GenoMAGIC, we expect to provide our plant breeders with a more comprehensive view to improving their analyses and decisions,” said Tom Osborn, Monsanto’s molecular breeding technology director.
“Monsanto is a global leader in technology that provides farmers with high-yielding seed hybrids and varieties, and we are proud that they have selected GenoMAGIC as a tool to support their advanced breeding programs. Partnering with companies like Monsanto – combined with our recent achievements, including being the first to map the wheat genome – are significant milestones on our roadmap to becoming the worldwide leader in genomic big data solutions,” added Dr Gil Ronen, CEO, NRGene.
© Worldofchemicals news
Read More: Monsanto, NRGene sign licensing agreement for genome analysis technology
No comments:
Post a Comment